Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Charles T. Quinn, MD, MS
Healthcare Provider Medical Director
Cincinnati Children's Hospital
Erythrocyte Diagnostic Laboratory
3333 Burnet Avenue
Cincinnati, Ohio, United States
Dr. Quinn is Associate Professor of clinical pediatrics at the University of Cincinnati College of Medicine and Cincinnati Children’s Hospital Medical Center. He has a long-standing interest in sickle cell anemia and thalassemia. He serves on the ASH Committee on Educational Affairs and on the Publications Committee. Dr. Quinn is one of the resident pediatric hematologists at Cincinnati Children’s Hospital Medical Center.
Clinical Interests:
Sickle cell disease; thalassemia; hemoglobinopathies; anemia; autoimmune hemolytic anemia; disorders of red blood cells; iron overload and iron chelation; chronic transfusion therapy; immune thrombocytopenia (ITP); neutropenia; stroke.
Research Interests:
Epidemiology, pathophysiology, treatment and prevention of brain injury (structural and cognitive) in sickle cell disease; measurement of red blood cell turnover in sickle cell disease; identification and treatment of cardiomyopathy and nephropathy in sickle cell disease; treatment and prevention of pain (VOC) in sickle cell disease; MRI methods of iron quantitation; new agents for immune thrombocytopenia (ITP)
Representative Publications:
Losartan for the nephropathy of sickle cell anemia: A phase-2, multicenter trial
Association between diffuse myocardial fibrosis and diastolic dysfunction in sickle cell anemia
Cardiomyopathy With Restrictive Physiology in Sickle Cell Disease
Acute silent cerebral infarction in children with sickle cell anemia
Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia
Related Content
-
Global Sickle Cell Disease Treatment Market 2019–2023| Evolving Opportunities with ADDMEDICA and Bristol-Myers Squ...The global sickle cell disease treatment...
-
Doris Duke Charitable Foundation awards grant to Critical Path InstituteIn a continuing effort to spur advance...
-
Allison A. King, MD, MPH, PhDDr. King is a pediatric hematologist and...
-
A Health Note From Dr. Biree Andemariam, SCDAA Chief Medical OfficerWhat You Need to Know About the Coronavi...
-
Predictors of acute care utilization and acute pain treatment outcomes in adults with sickle cell disease: The role ...Despite its rarity in the United States,...
-
Alan D. Michelson, MDDr. Michelson is Professor of Pediatrics...
-
4 Transition Stages of Sickle Cell Disease and Tips for Each Stagehttps://www.onescdvoice.com/wp-content/u...